Inventor
Julie HOROWITZ
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms18%
C12NMicroorganisms or enzymes14%
C12YEnzymes14%
C07KPeptides9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,472,241Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors202512,378,557Treatment of sepsis with PCSK9 and LDLR modulators202512,070,460Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors202411,752,197Macrophage stimulating 1 receptor (MST1R) variants and uses thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to REGENERON PHARMA (4)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 4 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2025 |